| Literature DB >> 27762345 |
Biswapriya B Misra1, Zepeng Yin1,2, Sisi Geng1, Evaldo de Armas3, Sixue Chen1,4.
Abstract
Global CO2 level presently recorded at 400 ppm is expected to reach 550 ppm in 2050, an increment likely to impact plant growth andEntities:
Mesh:
Substances:
Year: 2016 PMID: 27762345 PMCID: PMC5071901 DOI: 10.1038/srep35778
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Light and HCO3− concentration-dependent common and unique metabolites during the treatment.
(A) A two-way Venn diagram showing common and unique metabolites in light and dark conditions. (B) A three-way Venn diagram showing common and unique metabolites in different concentrations (1, 3, and 10 mM) in the time-course study.
Within subject-ANOVA showing enriched pathways based on significantly changed metabolites for time, light, treatment, concentrations, and their interactions.
| Pathways | Total Metabolites | Hits | P-value |
|---|---|---|---|
| Taurine and hypotaurine metabolism | 5 | 2 | 0.04117 |
| Flavone and flavonol biosynthesis | 9 | 4 | 0.003184 |
| Flavonoid biosynthesis | 43 | 9 | 0.00434 |
| Glutathione metabolism | 26 | 6 | 0.012087 |
| Phenylalanine metabolism | 8 | 3 | 0.019084 |
| Flavone and flavonol biosynthesis | 9 | 4 | 7.77E-04 |
| Taurine and hypotaurine metabolism | 5 | 2 | 0.025468 |
| Flavone and flavonol biosynthesis | 9 | 5 | 0.004267 |
| Flavonoid biosynthesis | 43 | 11 | 0.032193 |
| Glutathione metabolism | 26 | 7 | 0.063731 |
| beta-Alanine metabolism | 12 | 4 | 0.07746 |
| Pyrimidine metabolism | 38 | 9 | 0.077932 |
| Purine metabolism | 61 | 13 | 0.079759 |
| Phenylalanine metabolism | 8 | 3 | 0.09171 |
| Tyrosine metabolism | 18 | 5 | 0.099267 |
| Glyoxylate and dicarboxylate metabolism | 17 | 2 | 0.035261 |
| Alanine, aspartate and glutamate metabolism | 22 | 2 | 0.056748 |
| Taurine and hypotaurine metabolism | 5 | 1 | 0.086283 |
Figure 2Hierarchical cluster analysis (HCA) analysis of the mean values of metabolite contents.
Results are from four biological replicates showing 229 metabolites common to all the treatments depicting the data structure dependent on light, concentrations, and time course (0–120 min) of HCO3− treatment. Red and green indicate high and low concentrations of metabolites, respectively. Values were subjected to average linkage clustering (Euclidean distance).
Figure 3Correlation among samples and metabolites in the study.
(A) Samples pair-wise correlation heat map for control and HCO3− treated time-course profiling study (0, 5, 15, 30 60, 120 min). Columns and rows refer to the samples represented as a function of metabolites. Clustering on correlation coefficients demonstrate the grouping of samples based on their ‘metabotype’. (B) Metabolites pair-wise correlation heat map for control and HCO3− treated time-course profiling study (0, 5, 15, 30 60, 120 min). Columns and rows refer to metabolites arranged based on the Pearson correlation co-efficient. Highly correlated (red) metabolites in both cell-types belong to sugars and amino acids as compared to the lowly correlated ones (green).
Figure 4Short Time series Expression Miner (STEM) analysis displaying patterns of metabolite changes in dark and light conditions across the HCO3− treatment concentrations.
The numbers in the bottom left corner indicate number of metabolites following the pattern, while the numbers on top left indicate the serial number of the predicted model out of the 10 generated models, where only the top four models for each conditions are shown.
Figure 5Orthogonal partial least square discriminant (OPLS-DA) analysis of metabolites.
Alterations in A. thaliana suspension cells showed the effect of HCO3−. (A) treatment, (B) light conditions, (C) concentration, and (D) time-course upon HCO3− treatment. OPLS-DA was performed using four replicates data of relative metabolite abundance in samples at 0, 5, 15, 30, 60, 120 min, and the generated PC1 and PC2 were plotted.
Figure 6Principal component analysis of the GC-MS-based metabolites.
(A) Loading plot displaying the contribution of individual metabolites; (B) Variable importance in projections (VIP) scores of top 10 metabolites obtained from the PLS-DA analysis.